Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Vague or promotional

Rules 1.1.0 · as of 14 Sep 2026

Quote

Vague or promotional

“I think their effect sizes are going to be undeniable. They will be different in different patient populations, but we have at least 7 psychiatric disorder treatments—lysergide, comp360, ibogaine derivatives, methylone, DMT, 5-MEO-DMT, MDMA and it’s enantomers, all of which are looking as remarkable as GLP-1s are for metabolic disorders.”
· The Best Depression Drug Results Ever? · substack post Paid

Closing argument. The author predicts the effect sizes of psychedelic medicines (lysergide, COMP360, ibogaine derivatives, methylone, DMT, 5-MeO-DMT, MDMA and its enantiomers) will be undeniable and compares them to GLP-1s for metabolic disorders.

No entity, observable event, benchmark or threshold can be written from the text and its immediate context. Slogans ('game changer', 'once-in-a-lifetime opportunity', 'favourite stock') and quantifiers with no countable set ('more', 'first', 'all') without a defined set.